Epigenomics AG NA buy papaver
Start price
23.12.17
/
50%
€4.09
Target price
25.06.18
€5.10
Performance (%)
-41.20%
End price
25.06.18
€2.41
Summary
This prediction ended on 25.06.18 with a price of €2.41. Massive losses of -41.20% were the result for the BUY prediction by papaver. papaver has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Epigenomics AG NA | - | - | - | - |
| iShares Core DAX® | -1.553% | -0.123% | 12.654% | 57.846% |
| iShares Nasdaq 100 | -0.386% | -0.595% | 4.546% | 93.736% |
| iShares Nikkei 225® | 1.640% | 5.468% | 17.939% | 51.788% |
| iShares S&P 500 | 0.114% | -0.217% | 1.586% | 61.648% |
Comments by papaver for this prediction
In the thread Epigenomics AG NA diskutieren
Günstig
Vor dem übernahmeversuch stand der Aktienkurs bei +/-- 5,00 Euro.
Inzwischen ist der Test Epicolon in Amerika eingeführt und mit einem Medikament gegen Lungenkrebs kommt die Firma gut voran.
(Laufzeit überschritten)